Clinical Trial Update: Epidiolex® for Anxiety in Pediatric Epilepsy [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Epidiolex for anxiety in pediatric epilepsy has completed; no results are provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Epilepsy

Drugs mentioned

• EPIDIOLEX (Cannabidiol)

Snippet

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | Conditions: Anxiety, Epilepsy | Phase 4 | Status: COMPLETED